Multi-center Study to Transplant Hepatitis-C Infected Kidneys

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Raymond Chung
Study ID
NCT03781726
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Open label multi center study for the donation of HCV positive kidneys to HCV negative recipients with interventional treatment to prevent HCV transmission upon transplantation.

Key Dates

Start date
Apr 10, 2019
Status verified
Jan 2022
Primary completion
Mar 20, 2020
Completion
Dec 31, 2021

Study Design

Enrollment
30 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Treatment with glecaprevir/pibrentasvir Fixed Dose Combination
    8 weeks of HCV treatment with combination tablet of glecaprevir and pibrentasvir

Primary Outcome Measure

Number of Participants With Undetectable HCV [ Time Frame: 12 weeks post treatment ]

Locations (7)

FacilityCityStateZIPSite coordinators
Northwestern MedicineChicagoIllinois60611-
John HopkinsBaltimoreMaryland21287-
Massachusetts General HospitalBostonMassachusetts02114-
University of MichiganAnn ArborMichigan48109-
Weill Cornell Medical CenterNew YorkNew York10065-
University of Cincinnati Medical CenterCincinnatiOhio45219-
University of PennsylvaniaPhiladelphiaPennsylvania19104-

Find similar trials in Chicago, IL

By research site
Northwestern Medicine· Chicago, ILJohn Hopkins· Baltimore, MDMassachusetts General Hospital· Boston, MAUniversity of Michigan· Ann Arbor, MIWeill Cornell Medical Center· New York, NYUniversity of Cincinnati Medical Center· Cincinnati, OH

Related Studies